ATE173510T1 - Prüfung auf ein vielfache resistenz gegen antibiotika verursachendes operon - Google Patents

Prüfung auf ein vielfache resistenz gegen antibiotika verursachendes operon

Info

Publication number
ATE173510T1
ATE173510T1 AT93920397T AT93920397T ATE173510T1 AT E173510 T1 ATE173510 T1 AT E173510T1 AT 93920397 T AT93920397 T AT 93920397T AT 93920397 T AT93920397 T AT 93920397T AT E173510 T1 ATE173510 T1 AT E173510T1
Authority
AT
Austria
Prior art keywords
operon
disclosed
antibiotics
testing
multiple resistance
Prior art date
Application number
AT93920397T
Other languages
English (en)
Inventor
Stuart B Levy
Original Assignee
Tufts College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tufts College filed Critical Tufts College
Application granted granted Critical
Publication of ATE173510T1 publication Critical patent/ATE173510T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT93920397T 1992-08-28 1993-08-27 Prüfung auf ein vielfache resistenz gegen antibiotika verursachendes operon ATE173510T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US93808592A 1992-08-28 1992-08-28

Publications (1)

Publication Number Publication Date
ATE173510T1 true ATE173510T1 (de) 1998-12-15

Family

ID=25470856

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93920397T ATE173510T1 (de) 1992-08-28 1993-08-27 Prüfung auf ein vielfache resistenz gegen antibiotika verursachendes operon

Country Status (5)

Country Link
US (4) US5817793A (de)
EP (1) EP0658213B1 (de)
AT (1) ATE173510T1 (de)
DE (1) DE69322166T2 (de)
WO (1) WO1994005810A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5989832A (en) * 1995-04-21 1999-11-23 Microcide Pharmaceuticals, Inc. Method for screening for non-tetracycline efflux pump inhibitors
WO1998037188A1 (en) * 1997-02-21 1998-08-27 Hybridon, Inc. OLIGONUCLEOTIDES SPECIFIC FOR THE marORAB OPERON
US6068972A (en) 1997-10-03 2000-05-30 Trustees Of Tufts College Methods and compositions for reducing bacterial tolerance to antibacterials, disinfectants and organic solvents
ATE284443T1 (de) * 1998-02-19 2004-12-15 Eastern Virginia Med School Rekombinantes aktives humänes zona pellucida protein 3 (hzp3)
US7037663B2 (en) * 1998-02-19 2006-05-02 Eastern Virginia Medical School Human zona pellucida protein 3 and uses thereof
WO1999045152A1 (en) * 1998-03-06 1999-09-10 E.I. Du Pont De Nemours And Company Methods for identifying polycationic, peptide-like compounds with antibacterial activity
EP1080232A2 (de) * 1998-05-22 2001-03-07 Tufts University Helix-turn-helix domänen der mara familie und methoden zu deren verwendung
US6346391B1 (en) 1999-07-22 2002-02-12 Trustees Of Tufts College Methods of reducing microbial resistance to drugs
US7405235B2 (en) * 2001-05-04 2008-07-29 Paratek Pharmaceuticals, Inc. Transcription factor modulating compounds and methods of use thereof
EP1524974A4 (de) * 2001-05-04 2007-12-05 Paratek Pharm Innc Transkriptionsfaktor modulierende verbindungen und verfahren zur verwendung davon
AU2002365111A1 (en) * 2001-07-13 2003-07-15 Paratek Pharamaceuticals, Inc. Methods for identifying and using marr family polypeptide binding compounds
US20060084678A1 (en) * 2001-07-13 2006-04-20 Paratek Pharmaceuticals, Inc. Methods for identifying and using MarR family polypeptide binding compounds
US7202339B2 (en) * 2001-07-13 2007-04-10 Trustees Of Tufts College Crystals of MarR polypeptides, regulators of multiple antibiotic resistance
US7148021B2 (en) * 2001-08-02 2006-12-12 Eastern Virginia Meical School Human zona pellucida proteins and methods of their use in diagnosing male infertility
GB0123401D0 (en) * 2001-09-28 2001-11-21 Novartis Forschungsstiftung Methods of inducing gene expression
US20040106553A1 (en) * 2002-06-24 2004-06-03 Alekshun Michael N. Methods for preventing and treating microbial infections by modulating transcription factors
WO2004000228A2 (en) * 2002-06-24 2003-12-31 Paratek Pharmaceuticals, Inc. Methods for preventing and treating microbial infections by modulating transcription factors
WO2006076009A2 (en) 2004-04-23 2006-07-20 Paratek Pharmaceuticals, Inc. Transcription factor modulating compounds and methods of use thereof
RU2394911C2 (ru) 2005-05-11 2010-07-20 Кр. Хансен А/С Новые чувствительные к антибиотикам штаммы молочнокислых бактерий
US20090131481A1 (en) * 2007-03-27 2009-05-21 Paratek Pharmaceuticals, Inc. Transcription Factor Modulating Compounds and Methods of Use Thereof
IL194617A0 (en) * 2008-10-07 2009-11-18 Opticul Diagnostics Ltd Device and method for spectrometric identification of antibiotic resistance microbes
WO2010124097A2 (en) * 2009-04-22 2010-10-28 Paratek Pharmaceuticals, Inc. Transcription factor modulating compounds and methods of use thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992004458A1 (en) * 1990-09-11 1992-03-19 The Brookdale Hospital Medical Center Drug resistance screening method
JP3029533B2 (ja) * 1994-04-12 2000-04-04 シャープ株式会社 画像形成装置
DE69735817T2 (de) * 1996-12-19 2007-01-18 Matsushita Electric Industrial Co., Ltd., Kadoma Optische disk und verfahren zur aufzeichnung auf einer optischen disk
US6070799A (en) * 1997-01-08 2000-06-06 Eastman Kodak Company Copy protection for a recordable medium and for controlling a recorder
TW408290B (en) * 1997-12-29 2000-10-11 Samsung Electronics Co Ltd Method and apparatus for protecting copyright of digital recording medium and copyright protected digital recording medium
TW470946B (en) * 1999-07-15 2002-01-01 Matsushita Electric Industrial Co Ltd Optical recording medium and method for recording optical recording medium
JP3292181B2 (ja) * 1999-09-20 2002-06-17 ヤマハ株式会社 Ｃｄ−ｒｗディスクの消去方法およびｃｄ−ｒｗ記録装置
JP2001291244A (ja) * 2000-04-04 2001-10-19 Sharp Corp 光記録媒体、光記録情報の再生方法並びに再生装置
US7302588B2 (en) * 2000-06-27 2007-11-27 Sony Corporation Data recording method, data recording device, and recording medium

Also Published As

Publication number Publication date
EP0658213B1 (de) 1998-11-18
DE69322166T2 (de) 1999-04-22
EP0658213A1 (de) 1995-06-21
DE69322166D1 (de) 1998-12-24
WO1994005810A1 (en) 1994-03-17
US5817793A (en) 1998-10-06
US20030013104A1 (en) 2003-01-16
US6391545B1 (en) 2002-05-21
US20050136460A1 (en) 2005-06-23

Similar Documents

Publication Publication Date Title
ATE173510T1 (de) Prüfung auf ein vielfache resistenz gegen antibiotika verursachendes operon
BR9610511B1 (pt) construções de dna, úteis em terapia genética, compreendendo ao menos uma sequência nucléica de interesse e composição farmacêutica.
DK0556345T3 (da) Retrovirale vektorer,som er egnede til genterapi
UA66417C2 (en) Recombinant adenovirus affecting canines, pharmaceutical composition
FI970656A0 (fi) Painonsäätelyaineet, vastaavat nukseiinihapot ja proteiinit ja näiden diagnostiset ja terapeuttiset käytöt
BR8302318A (pt) Ativador de plasminogenio de tecido humano,seguencia de dna,vetor de expressao replicavel,plasmideo,microorganismo ou cultura celulor,composicao,uso do dito ativador,processo de expressao,e processo para produzir t pa humano
DE69637844D1 (de) Neues tgf-beta-ahnliches cytokin
ATE128185T1 (de) Bacillus thuringiensis gen, protein und seine verwendung.
NO973685L (no) Multi-tumor avvikende vekstgener
NZ320889A (en) A p35 protein which binds to and inhibits chemokines
DK381189A (da) N-2,3-butadienyl-tri- og -tetraaminoalkanderivater og deres anvendelse
EA200100700A1 (ru) Гены и белки и их применение
DE69736276D1 (de) Menschliche dnase resistent gegen actininhibitoren
DK0804465T3 (da) Nye elastaseinhibitorer
BR9714641A (pt) Mutantes de toxina a de estreptococo e métodos de uso
ATE249521T1 (de) Nachweis von enterobakterien
FR2694294B1 (fr) Promoteur de levure et son utilisateur.
AU6193699A (en) Antisense-sequences for inhibiting the expression of the adhesion molecule icam-1
GR1000679B (el) Γονιδιο τοξινης p-2 bacillus thuringiensis,πρωτεινη και σχετικες εντομοκτονες συνθεσεις.
PT714441E (pt) Alergenios recombinantes de cladosporium herbarum
ATE278011T1 (de) Human dnase ii
FI911441L (fi) Menetelmä antibioottien tuottamiseksi, siinä käyttökelpoisia DNA-jaksoja, yhdistelmä-DNA-konstruktioita ja näitä sisältäviä mikrobikantoja
EA200100701A1 (ru) Белки наружной поверхности, их гены и их применение
DE59408697D1 (de) Multicistronische expression rekombinanter gene in bakterienzellen
BR0305435A (pt) Utilização de pelo menos um fragmento polinucleotìdico, de pelo menos um marcador e de uma combinação de pelo menos dois fragmentos polinucleotìdicos, processo para o diagnóstico de uma predisposição ao encanecimento precoce em um indivìduo, e, kit

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification